-
-
E610105-25mgelsubrutinib.
-
E610105-5mgelsubrutinib.
-
E414000-10mgInformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is
-
E414000-25mgInformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is
-
E414000-2mgInformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is
-
E414000-50mgInformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is
-
E414000-5mgInformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706,ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is
-
-
-
-